Quarterly ResultAug 3, 2026, 02:31 PM
Fresenius Medical Care Q2 2026 Operating Income EUR 569M, beats expectations
AI Summary
Fresenius Medical Care reported Q2 2026 operating income, excluding special items, of EUR 569 million, a 23% increase at constant currency, surpassing market expectations of EUR 515 million. Group revenue rose 4% at constant currency to EUR 4,861 million, also slightly above consensus. The company confirmed its unchanged financial outlook for the full year 2026.
Key Highlights
- Q2 2026 operating income (excl. special items) was EUR 569 million.
- Operating income grew 23% year-over-year at constant currency.
- Operating income exceeded market consensus of EUR 515 million.
- Q2 2026 group revenue was EUR 4,861 million.
- Group revenue grew 4% year-over-year at constant currency.
- Group revenue slightly exceeded market consensus of EUR 4,792 million.
- Company confirmed its full-year 2026 financial outlook.
Price Impact
More from FMS